Proscia
Pathology AI. #1 Best in KLAS. Enterprise-grade intelligence for the decisions that matter most.
Published Oct 15, 2026
The vendor publishes adoption-related claims about customer numbers and usage volumes. These are vendor-supplied figures and should be validated with procurement and reference checks.
| Starting Price | Custom / not publicly listed (enterprise agreements typical) | Custom / not publicly listed (enterprise programs common) | Public self-serve tiers available for cloud storage and basic sharing; enterprise education pricing varies |
| Best For | Labs and pharma requiring WSI management, integrations, and an FDA-cleared primary diagnostic option in the US | Health systems integrating pathology into enterprise imaging programs | Education, conferences, and slide sharing with transparent self-serve storage tiers |
| Key Strength | Interoperability efforts (SDK integrations, DICOM support), regulated clinical pathway option | Enterprise imaging alignment and provider footprint in certain regions | Clear usability for sharing and teaching, transparent storage tiers for public offerings |
| Key Weakness | Limited public third-party review volume on major review platforms; pricing opacity | Pricing opacity; may be more suitable for larger enterprise imaging programs | Not positioned primarily for FDA-cleared primary diagnostic workflows; institutional enterprise pricing may vary |
—